Searchable abstracts of presentations at key conferences in endocrinology

ea0026p582 | Cardiovascular endocrinology and lipid metabolism | ECE2011

Heme-oxigenase mediates cardiovascular protection by oestrogen and raloxifene in menopause

Posa A , Varga C S , Berko A M , Veszelka M , Szabo R , Orban K , Pavo I , Laszlo F

Introduction: Selective oestrogen receptor modulators function as oestrogen receptor antagonist in the breast and gonads, while they have agonistic effects on the bone and the cardiovascular system. It is also known that endogenously produced carbon monoxide by the heme-oxigenase (HO) enzyme exerts beneficial actions in cardiovascular protection.Design: Intact females, ovariectomized (OVX), raloxifene or oestrogen treated OVX Wistar rats were used. We st...